The bench blog
Field notes with receipts.
Everything published here runs on the same open dataset you can download, and clinical claims wait for a physician's sign-off before any badge appears. If a post can't cite its receipts, it doesn't ship.
Latest from the market desk
Dated articles generated from the price dataset; every figure carries the day it was read on the provider’s page.
- Compounded Tirzepatide Online Price on September 17, 2026: The Lowest Figures, Program by Program, and What Each One Actually Is Money page · price questions · September 18, 2026
Read on the providers' own pages, year-one math applied: 26 priced compounded tirzepatide programs, from $86 a month all-in to $349. The lowest stickers are a membership paid for the year, a promotion with its end date at checkout and a prepaid supply with all payments final; the lowest standing rate charged monthly is $139/month on NexLife’s 12-month plan, charged monthly ($169 month-to-month, $0 membership). - Cheap Tirzepatide Online Without Insurance: Every Compounded Plan Under $200 a Month on September 17, 2026, With the Condition Printed on Each Money page · price questions · September 18, 2026
Insurance does not cover compounded tirzepatide, so the question is a cash question. On September 17, 2026 the plans at or below $200 a month all-in, read on the providers' own pages, sort into four kinds — a membership paid for the year, promotional rates, prepaid supplies and standing rates charged monthly — and the sorting decides what you have paid if you stop early.
Lead story
Cheapest Compounded Tirzepatide Online: We Shopped Six Programs — Here Are the Year-One Receipts
Month one, month seven, and the exit — receipts from six checkouts, the ~$1,080 step-up tax quantified, the 2026 legal lane in two paragraphs, and the three trial results that explain the demand. MEDICALLY REVIEWED · AUG 17, 2026
~2,400 words · updated Aug 17, 2026 · raw data
The Compounding Pharmacy Tour
Prescription to doorstep — cleanrooms, COAs, QC, and BUD logic. METHOD
Cold-Chain Failure Playbook
Warm packs, late boxes — document, call, and never guess the verdict. LOGISTICS
The Maintenance Interval Question
Every 10–14 days? Plausible, unproven, prescriber-owned — the framework. MEDICALLY REVIEWED · AUG 2026
Brain Fog & Fatigue
Five suspects in checking order, the two-week protocol, the flag lanes. MEDICALLY REVIEWED · AUG 2026
The Restart File
Round two, done right — starter-dose truth, gap-year re-shop, retired shame. MEDICALLY REVIEWED · AUG 2026
The Second-Year Plateau
Flat at year two is usually the fight being won — the verdict and the levers. MEDICALLY REVIEWED · AUG 2026
The Shortage Contingency File
Three layers built in calm weather — buffer, second lane, flexibility on record. LOGISTICS
Vials vs Pens: Ergonomics
What the premium buys, who should pay it, and the training that shrinks the gap. METHOD
The Family Announcement Script
Who needs to know, who gets to know — and the exact words for both. METHOD
Reading FDA Warning Letters
Serious signal, not a verdict — anatomy, triage, and the close-out check. METHOD
The Six-Month Photo Audit
Three passes, three verdicts — the review that turns pictures into a plan. METHOD
After Hims: The Tirzepatide Migration Guide
Records, bridge timing, the corrected 2026 field, and the seven-day plan. MEDICALLY REVIEWED · AUG 2026
Is Compounded Semaglutide Going Away?
Proposal vs law, the scenario map, structural readiness, and the fear economy. MEDICALLY REVIEWED · AUG 2026
Foundayo (Orforglipron): The Decision File
The no-rules pill — approval facts, honest efficacy, the price ladder, the fit test. MEDICALLY REVIEWED · AUG 2026
The $50 Question: Bridge & TrumpRx Decoded
Who actually pays what in 2026 — by insurance status, fine print included. MEDICALLY REVIEWED · AUG 2026
GLP-1s for PCOS: The Honest File
Mechanism, thin-but-growing evidence, the fertility landmine, the coverage maze. MEDICALLY REVIEWED · AUG 2026
CagriSema in 2026: The Status File
Filed, reviewing, undated — the trial honesty and the math against waiting. MEDICALLY REVIEWED · AUG 2026
Zepbound vs Wegovy: The 2026 Verdict
The head-to-head trial, the label levers, the two price ladders. MEDICALLY REVIEWED · AUG 2026
Latest from the queue
Microdosing GLP-1s: A Fair Hearing for an Unproven Idea
The tolerability case, the dose-response math, and exactly where the trial record ends — with the only audited microdose prices in the field. MEDICALLY REVIEWED · AUG 2026
Hims vs Henry Meds: The Price of the Door
Commitment discount vs exit freedom, broken even at month eight — with the audited benchmark that sits below both. MEDICALLY REVIEWED · AUG 2026
SURMOUNT-5, Beyond the Headline
What 20.2% vs 13.7% actually compared — and the $240/year the gap costs at audited prices. MEDICALLY REVIEWED · AUG 2026
Stopping Tirzepatide: The Off-Ramp
SURMOUNT-4's regain data turned into a plan — muscle first, tripwires in writing, re-entry priced. MEDICALLY REVIEWED · AUG 2026
B12, Glycine, L-Carnitine: The Additive Audit
Why the vitamins are marketing, and the salt-form warning that isn't. MEDICALLY REVIEWED · AUG 2026
Stopping Semaglutide: The Extension Data
Two-thirds regained in the year off — and the sema-specific plan that respects it. MEDICALLY REVIEWED · AUG 2026
Tirzepatide: 60 Questions Answered
The answer bank — dosing to dollars, every answer sourced and schema-wired. MEDICALLY REVIEWED · AUG 2026
Semaglutide: 40 Questions Answered
The sister bank — STEP to salt forms to the $119 audited floor (and the $110 microdose figure, reported since September 17, 2026). MEDICALLY REVIEWED · AUG 2026
"From" Pricing Decoded
Eight qualifier instruments, field examples, and the ten-second parser. PRICING ANALYSIS
SURMOUNT-1, Reread
The 20.9% pivotal decomposed — plus the ~94% diabetes-prevention extension. MEDICALLY REVIEWED · AUG 2026
The Titration Ladder, Annotated
Every rung, "as tolerated" decoded — and what each step costs where pricing tiers. MEDICALLY REVIEWED · AUG 2026
First-Month Discounts, Annualized
The $99 door priced honestly: $2,288–$3,388 years, worked on the record. PRICING ANALYSIS
Muscle & Protein on GLP-1s
The DXA reality and the two-part counter-program that actually works. MEDICALLY REVIEWED · AUG 2026
STEP 1, Reread
The era-starter — and why it still wins dollars-per-percent at $1,428. MEDICALLY REVIEWED · AUG 2026
Prepay Refund Policies
The taxonomy from pro-rata to silence — and the $399-on-$133 effective-price math. PRICING ANALYSIS
Oral Semaglutide, Explained
SNAC chemistry, the 4-oz ritual, OASIS' 50 mg future — and the drops that skip the science. MEDICALLY REVIEWED · AUG 2026
The Pharmacokinetics of Forgiveness
Two half-lives, every rule derived: windows, rungs, travel, the long tail. MEDICALLY REVIEWED · AUG 2026
The Savings-Card Decoder
Tiers, caps, and the accumulator trap that eats deductibles quietly. PRICING ANALYSIS
Retatrutide, Tracked
The 24% triple agonist — and why every vial for sale today is a chemistry experiment. MEDICALLY REVIEWED · AUG 2026
Cold-Chain & the Porch Problem
Label windows, summer physics, and five written questions before anything ships. MEDICALLY REVIEWED · AUG 2026
The Semaglutide Switch Guide
Both directions mapped — no washout, honest resets, and where switches actually break. MEDICALLY REVIEWED · AUG 2026
The Red-Flags Field Manual
Fifteen tells, five categories, four instant disqualifiers — run it in ninety seconds. CONSUMER PROTECTION
Anatomy of a Winning Appeal
Four denial species, the five-part letter, and the external review nobody uses. COVERAGE ANALYSIS
Verify the Pharmacy Yourself
The five-link chain from public records — including the your-state check everyone skips. CONSUMER PROTECTION
Vial Math
One equation, five classic mistakes, and the FDA's 5–20× error reports. MEDICALLY REVIEWED · AUG 2026
Wegovy vs Compounded: $380/mo
Both cases at full strength — and the four-question sorter that makes the verdict yours. MEDICALLY REVIEWED · AUG 2026
Telehealth Law 101
The five-layer stack under every legitimate program — Ryan Haight myth retired. LEGAL ANALYSIS
Reading a COA
Four assays, gating metadata, ranked flags — five minutes to a verdict. MEDICALLY REVIEWED · AUG 2026
The Two-Line Price
Membership forensics: the fraction with a hidden denominator, totaled honestly. PRICING ANALYSIS
Autoship Law, Post-Vacatur
Click-to-cancel fell in 2025 — ROSCA and state ARLs are the real stack. LEGAL ANALYSIS
The 90-Day Fill Question
BUD clocks, the titration trap, and when bulk genuinely wins. MEDICALLY REVIEWED · AUG 2026
The SELECT Decoder
Who the CV claim covers — relative, absolute, and the NNT nobody quotes. MEDICALLY REVIEWED · AUG 2026
The Informed-Consent Teardown
Eight findable clauses — and the placement red flags that confess everything. LEGAL ANALYSIS
The Step-Down Lane
Tirzepatide results on semaglutide prices — the evidence map, drawn precisely. MEDICALLY REVIEWED · AUG 2026
The Two-Vial Month
Depletion tax, waste tax, dose-proof — three architectures under “monthly.” PRICING ANALYSIS
The Chargeback Ladder, Expanded
Five rungs, the right framings — and what the tool isn't for. CONSUMER PROTECTION
A ToS in Ten Minutes
Eight Ctrl-F searches, one expiring opt-out, and the calibration that matters. LEGAL ANALYSIS
GIP, Explained
The disgraced hormone's redemption arc — settled at the scoreboard, live at the mechanism. MEDICALLY REVIEWED · AUG 2026
Food Noise
The symptom patients named first — known vs plausible, the quieting and the return. MEDICALLY REVIEWED · AUG 2026
The Gallbladder File
The risk that rides the speed — symptom literacy and the go-now triad. MEDICALLY REVIEWED · AUG 2026
Pricing Archaeology
Four strata from shortage valve to the 2026 proposal — and how to read the fossils. MARKET ANALYSIS
Titration Holds
The art of staying put — and the hold-vs-quit line that saves therapies. MEDICALLY REVIEWED · AUG 2026
Zepbound Vials, Decoded
The ~$299-entry brand cash lane (Aug 2026; earlier $349) — what it keeps, surrenders, and competes with. PRICING ANALYSIS
Nausea Engineering
The comfort protocol from mechanics, not folklore — plus the red lines. MEDICALLY REVIEWED · AUG 2026
The Plateau Audit
Six causes in order — including the plateau that means it worked. MEDICALLY REVIEWED · AUG 2026
The SURMOUNT-OSA File
First-ever sleep-apnea indication — AHI decoded, CPAP answered, coverage door opened. MEDICALLY REVIEWED · AUG 2026
Reading “Best Of” Lists
Five tells, a sixty-second audit — run here on this site first. CONSUMER PROTECTION
The SUMMIT File
The heart failure nobody could treat — and the ~38% result against it. MEDICALLY REVIEWED · AUG 2026
The FLOW File
Kidneys, the trial stopped for working, and the organ résumé that picks molecules. MEDICALLY REVIEWED · AUG 2026
Alcohol on GLP-1s
Stale calibrations, stacked GI, sharpened edges — and the desire drop in real trials. MEDICALLY REVIEWED · AUG 2026
Pens, Needles, Sharps
Formats, rotation, technique, disposal law, and flying — the hardware layer. MEDICALLY REVIEWED · AUG 2026
The Second Opinion
Leave signals, the records right, and the exit sequence with no gap. CONSUMER PROTECTION
The Interactions File
The short list, the absorption story, and the two absolutes. MEDICALLY REVIEWED · AUG 2026
The Thyroid Warning, Sized
One rare cell type — not the thyroid as a category. MEDICALLY REVIEWED · AUG 2026
Loose Skin, Honestly
Six variables, graded interventions, the surgical lane — and proportion. MEDICALLY REVIEWED · AUG 2026
The Perioperative Pause
Anesthesia and the full stomach nobody can see — evolving guidance, told straight. MEDICALLY REVIEWED · AUG 2026
Birth Control on Tirzepatide
The four-week rule, the calendar math, and the fertility kicker. MEDICALLY REVIEWED · AUG 2026
Pregnancy & the Runway
The two-month rule derived, the discovered-pregnancy protocol, and the gap nobody plans. MEDICALLY REVIEWED · AUG 2026
Mood on GLP-1s
Headlines vs the regulator reviews — plus the watch-list and the anhedonia distinction. MEDICALLY REVIEWED · AUG 2026
Hair Shedding, On Schedule
Telogen effluvium's cruel lag, the recovery clock, and the two labs that matter. MEDICALLY REVIEWED · AUG 2026
Adolescent GLP-1s
Approved at 12+, different by design — and the bright line for online sellers. MEDICALLY REVIEWED · AUG 2026
The Data Nutrition Label
Tiers, dates, refusal rules — the dataset's own file, challengeable by design. METHODOLOGY
The Side-Effect Ledger in Words
Both molecules' AE tables translated — bands, time-course, the head-to-head verdict. MEDICALLY REVIEWED · AUG 2026
The Refill Cliff
Seven warnings, the half-life grace window, and the continuity playbook. CONSUMER PROTECTION
Injection-Day Rituals
Adherence engineering: anchors, rotation, timing, and pre-decided misses. MEDICALLY REVIEWED · AUG 2026
The Employer Lane
Self-funded plans, the SPD read, and the ask that reaches the real deciders. COVERAGE
Reading a Trial: Ten Questions
The site's own lens, handed over — with worked examples from the library. METHODOLOGY
503A vs 503B, Decoded
Two pharmacy species, the checkout questions, and the myth neither supports. REGULATORY
Travel With GLP-1s
TSA, time zones, and the cooler math that deletes most anxiety. MEDICALLY REVIEWED · AUG 2026
The Dose-Change Paper Trail
Six artifacts, one-sentence scripts, five disputes won in advance. CONSUMER PROTECTION
Sleep on GLP-1s
The apnea victory sized, the grumbles framed honestly, four experiments. MEDICALLY REVIEWED · AUG 2026
The Second Opinion
Specialist oversight at telehealth pricing — and the integrity tell. MEDICALLY REVIEWED · AUG 2026
The Lab Panel
The sensible baseline, the boutique shelf declined, and the one-question filter. MEDICALLY REVIEWED · AUG 2026
Grocery List, Rebuilt
Protein anchors, the nausea shelf, and the frozen-and-divided revolution. MEDICALLY REVIEWED · AUG 2026
Strength-Training Minimums
Two days, five patterns — the floor that defends what the scale can't see. MEDICALLY REVIEWED · AUG 2026
Dining Out on a GLP-1
Order like a scout, eat like a clock, box like an economist. MEDICALLY REVIEWED · AUG 2026
Compounded Quality Signals
BUDs, CoAs, and the four asks that sort pharmacies into leagues. CONSUMER PROTECTION
The Denial Letter, Translated
Five rejection reasons, five counters — and the external-review escalator. COVERAGE
The Cost of Quitting
The regain, restart, and opportunity lines vs the cheaper-than-quitting menu. PRICING
Reading Your EOB
Four columns, the accumulator check, and the three-error sweep. COVERAGE
Sublingual & ODT: The Evidence File
The needle-free premium graded — including our own anchor's lane. MEDICALLY REVIEWED · AUG 2026
Household Logistics
Two people, two molecules, one fridge — the full choreography. MEDICALLY REVIEWED · AUG 2026
Switching Molecules Mid-Course
No conversion chart — the calendar bridge, the expectation reset, the pricing traps. MEDICALLY REVIEWED · AUG 2026
Surgery Weight Thresholds
The GLP-1 runway when the OR sets your deadline — plus the perioperative hold. MEDICALLY REVIEWED · AUG 2026
The Renewal Review
The 30-minute annual audit August 2026 just proved necessary. PRICING
Community Wisdom, Filtered
What forums get right, what they get dangerously wrong, and the five-question screen. METHOD
The Waiting Room
Checkout to first dose: the corridor, the build list, the arrival checklist. MEDICALLY REVIEWED · AUG 2026
The Plateau Protocol Audit
Three drifts to check, in cost order, before anyone touches the dose. MEDICALLY REVIEWED · AUG 2026
Gifting & Family Funding
Consent first, known numbers, guilt-free exits — and the failure modes named. PRICING
The Two-Provider Household
The $4,392 worked case, the three exceptions, the no-gap merge. PRICING
Insurance Churn Survival
Horizon moves, the COBRA subtraction, the cash bridge, re-entry PA. COVERAGE
The Exit Interview
Stopping well: regain math, the taper question, paperwork, re-entry file. MEDICALLY REVIEWED · AUG 2026
The Data Export Ritual
Your portal is rented — the quarterly habit that makes you unstrandable. METHOD
Side-Effect Communication Scripts
The four-line template, the skip-the-inbox list, the escalation ladder. MEDICALLY REVIEWED · AUG 2026
The Long-Distance Patient
Moves, state lines, snowbirds, travel — licensure logistics, solved honestly. LOGISTICS
Auditing a New Entrant
The Trimi walk, pre-registered — ten checks published before we run them. METHOD
The Price-Match Letter
Three templates, ethical escalation, and the ~$25 stop-writing trigger. PRICING
The Anniversary Letter
The year-one retrospective that makes year two a decision. METHOD
Decoding Lab Panels
What moves, what it means, which numbers earn a call. MEDICALLY REVIEWED · AUG 2026
The Caregiver’s File
Logistics ally, never compliance officer — the full role description. MEDICALLY REVIEWED · AUG 2026
Photo Protocol
Monthly, marked, private — evidence that outvotes the mirror. METHOD
The Second Opinion Script
When, who, and the exact words — plus grading what you paid for. MEDICALLY REVIEWED · AUG 2026
The Insurance Appeal Diary
A denial walked to decision — every document named. COVERAGE
Cooking for Suppressed Appetites
The protein-first kitchen when appetite is the constraint. MEDICALLY REVIEWED · AUG 2026
The Maintenance Dose Conversation
Stay, step down, or stretch — plus the decade money math. MEDICALLY REVIEWED · AUG 2026
Reading Terms Like a Lawyer
Six clauses, ten minutes, one dated PDF. METHOD
The Restart Protocol
Round two on round one’s data — resumption, not failure. MEDICALLY REVIEWED · AUG 2026
The Dose Diary Template
Seven fields, sixty seconds — the artifact upstream of every hard moment. METHOD
Sharps Disposal, Solved
The $10 container, your local lane, and the travel protocol. LOGISTICS
The Refund Escalation Ladder
Six rungs — most cases end by two; the upper rungs make the lower ones work. CONSUMER
In the audit queue — from the 250-topic research plan
- Fifty 410, Audited: What the ~$133 Prepay Really Buys — the field's lowest sticker, stress-tested.
- Zepbound Savings Card 2026: The $25 Path and Who Qualifies — the cases where brand wins outright.
- Tirzepatide vs Retatrutide: Reading the Triple-Agonist Data — what Phase 3 does and doesn't show.
- The Shipping Map: Which States Each Program Actually Serves — closing the field's biggest open file.
Posts ship when their numbers survive an audit, not on a calendar. The full research plan spans 250 topics, weighted roughly 60% tirzepatide / 40% semaglutide.